Next-Generation TB Vaccines Could Save 7.3 Million Lives by 2050, Says Gavi
New tuberculosis vaccines expected to reach the market from 2029 could save an estimated 7.3 million lives and generate up to $135 billion in economic benefits for low- and middle-income countries by 2050, ending more than a century of reliance on a single licensed TB vaccine.